Anti-Tumor 99% Pharm Grade USP Vincristine Sulfate CAS 2068-78-2

Vincristine sulfate desription: 

A natural plant antineoplastic drug used in the treatment of acute leukemia and malignant lymphoma, small cell lung cancer, and breast cancer. Widely used in cancer research, multi drug inhibition, monoamine oxidase (monoamine, oxidase) inhibitors. This product can affect the formation of spindle cells, the mitotic arrest in the middle of the cell cycle in M phase delaying or blocking effect. In addition, the synthesis of purine, RNA and DNA can be inhibited. This drug is a cell cycle specific drugs. It is mainly used for the treatment of acute lymphoblastic leukemia, He Jie's disease, malignant lymphoma, small cell lung cancer, breast cancer, ovarian cancer, digestive tract cancer and so on.

Vincristine sulfate,also known as leurocristine sulfate,is a chemotherapy medication used to treat a number of types of cancer.This includes acute lymphocytic leukemia, acute myeloid leukemia, Hodgkin's disease, neuroblastoma, and small cell lung cancer among others.

Vincristine sulfate application: 

Vincristine sulfate is mainly used for clinical treatment of acute lymphoblastic leukemia, Hodgkin's disease, malignant lymphoma, small cell lung cancer, breast cancer, ovarian cancer, gastrointestinal cancer, and so on.